Novanta Inc. (NASDAQ:NOVT – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $140.53 and last traded at $143.43, with a volume of 12456 shares. The stock had previously closed at $143.17.
Analysts Set New Price Targets
Separately, Robert W. Baird dropped their target price on shares of Novanta from $175.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, November 6th.
Novanta Stock Performance
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the company. Sanctuary Advisors LLC acquired a new position in shares of Novanta during the 3rd quarter valued at about $232,000. KBC Group NV lifted its position in Novanta by 41.6% in the fourth quarter. KBC Group NV now owns 1,500 shares of the technology company’s stock valued at $229,000 after buying an additional 441 shares during the last quarter. Exchange Traded Concepts LLC lifted its position in Novanta by 4.0% in the fourth quarter. Exchange Traded Concepts LLC now owns 120,566 shares of the technology company’s stock valued at $18,419,000 after buying an additional 4,648 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Novanta by 110.2% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 100,259 shares of the technology company’s stock valued at $17,938,000 after buying an additional 52,573 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in Novanta by 1.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 439,390 shares of the technology company’s stock valued at $78,616,000 after buying an additional 4,271 shares during the last quarter. Institutional investors and hedge funds own 98.35% of the company’s stock.
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Featured Articles
- Five stocks we like better than Novanta
- What is the Hang Seng index?
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Stock Analyst Ratings and Canadian Analyst Ratings
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How to Invest in Insurance Companies: A Guide
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.